|
OMIM |
Link |
Information gain |
01 |
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.00204613
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.00184633
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000955936
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000912577
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.000912577
|
|
|
IDDM7
|
[NCBI]
|
0.000702392
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.000638637
|
|
|
IGAD1
|
[NCBI]
|
0.000565232
|
|
|
MBP
|
[NCBI]
|
0.000469123
|
|
|
RA
|
[NCBI]
|
0.00040248
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000395927
|
|
|
TNF
|
[NCBI]
|
0.000389091
|
|
|
EV
|
[NCBI]
|
0.000305591
|
|
|
SLE
|
[NCBI]
|
0.000277867
|
|
|
IL2
|
[NCBI]
|
0.000273677
|
|
|
CHH
|
[NCBI]
|
0.000264017
|
|
|
IS
|
[NCBI]
|
0.000212521
|
|
|
IDDM
|
[NCBI]
|
0.000199799
|
|
|
HIGM1
|
[NCBI]
|
0.00018931
|
|
|
kaposi sarcoma
|
[NCBI]
|
0.000181992
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000177922
|
|
|
MG
|
[NCBI]
|
0.000175939
|
|
|
WAS
|
[NCBI]
|
0.000173764
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000165592
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
0.00016241
|
|
|
CEACAM5
|
[NCBI]
|
0.00015625
|
|
|
TNFSF6
|
[NCBI]
|
0.000148751
|
|
|
CHS
|
[NCBI]
|
0.000118288
|
|
|
inosine phosphorylase deficiency, immune defect due to
|
[NCBI]
|
0.00010886
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
0.00010886
|
|
|
OLEDAID
|
[NCBI]
|
0.00010886
|
|
|
hypersensitivity pneumonitis, familial
|
[NCBI]
|
0.00010886
|
|
|
monocyte chemotactic disorder
|
[NCBI]
|
0.00010886
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.00010886
|
|
|
CVID
|
[NCBI]
|
0.000106496
|
|
|
ADA
|
[NCBI]
|
0.000104909
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
0.000100911
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
9.80355e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
8.90955e-05
|
|
|
CF
|
[NCBI]
|
8.59722e-05
|
|
|
AD
|
[NCBI]
|
8.574e-05
|
|
|
TLR9
|
[NCBI]
|
8.15977e-05
|
|
|
buerger disease
|
[NCBI]
|
8.11733e-05
|
|
|
ataxic diplegia with defective cellular immunity
|
[NCBI]
|
8.11733e-05
|
|
|
immunodeficiency, partial combined, with absence of hla determinants and beta-2-microglobulin from lymphocytes
|
[NCBI]
|
8.11733e-05
|
|
|
DKC
|
[NCBI]
|
7.30144e-05
|
|
|
CRC
|
[NCBI]
|
6.40862e-05
|
|
|
goodpasture syndrome
|
[NCBI]
|
6.40576e-05
|
|
|
tuftsin deficiency
|
[NCBI]
|
6.40576e-05
|
|
|
AT
|
[NCBI]
|
6.10105e-05
|
|
|
EGF
|
[NCBI]
|
5.96971e-05
|
|
|
TINU
|
[NCBI]
|
5.90829e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
5.90829e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
5.51364e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
5.51364e-05
|
|
|
HAM
|
[NCBI]
|
5.51364e-05
|
|
|
BCGF
|
[NCBI]
|
4.96333e-05
|
|
|
vitiligo
|
[NCBI]
|
4.90849e-05
|
|
|
HPS2
|
[NCBI]
|
4.90849e-05
|
|
|
IL4
|
[NCBI]
|
4.86667e-05
|
|
|
TNFSF7
|
[NCBI]
|
4.73509e-05
|
|
|
IL12RB2
|
[NCBI]
|
4.73509e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
4.66616e-05
|
|
|
GS2
|
[NCBI]
|
4.66616e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
4.45185e-05
|
|
|
HHS
|
[NCBI]
|
4.08629e-05
|
|
|
AEZ
|
[NCBI]
|
3.9279e-05
|
|
|
THY1
|
[NCBI]
|
3.68771e-05
|
|
|
APS1
|
[NCBI]
|
3.36821e-05
|
|
|
bladder cancer
|
[NCBI]
|
3.29731e-05
|
|
|
UCMD
|
[NCBI]
|
3.00652e-05
|
|
|
RP
|
[NCBI]
|
2.97798e-05
|
|
|
LIP
|
[NCBI]
|
2.75912e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
2.75912e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.61297e-05
|
|
|
CD160
|
[NCBI]
|
2.56791e-05
|
|
|
CD1C
|
[NCBI]
|
2.56791e-05
|
|
|
CCR8
|
[NCBI]
|
2.56791e-05
|
|
|
IHG
|
[NCBI]
|
2.56791e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.51523e-05
|
|
|
CCL21
|
[NCBI]
|
2.51245e-05
|
|
|
NGFB
|
[NCBI]
|
2.47712e-05
|
|
|
NP
|
[NCBI]
|
2.41997e-05
|
|
|
DSG3
|
[NCBI]
|
2.39804e-05
|
|
|
CD72
|
[NCBI]
|
2.36694e-05
|
|
|
TIA1
|
[NCBI]
|
2.36694e-05
|
|
|
CCR4
|
[NCBI]
|
2.36694e-05
|
|
|
CD5
|
[NCBI]
|
2.36694e-05
|
|
|
VEGF
|
[NCBI]
|
2.26644e-05
|
|
|
LILRA2
|
[NCBI]
|
2.21779e-05
|
|
|
DNTT
|
[NCBI]
|
2.14782e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
2.13631e-05
|
|
|
CD1B
|
[NCBI]
|
2.09918e-05
|
|
|
SET
|
[NCBI]
|
2.09918e-05
|
|
|
XLP1
|
[NCBI]
|
2.08614e-05
|
|
|
CLL
|
[NCBI]
|
2.08614e-05
|
|
|
TICAM1
|
[NCBI]
|
2.00074e-05
|
|
|
KLRA1
|
[NCBI]
|
2.00074e-05
|
|
|
CD22
|
[NCBI]
|
2.00074e-05
|
|
|
CCR1
|
[NCBI]
|
2.00074e-05
|
|
|
ATS
|
[NCBI]
|
1.99075e-05
|
|
|
KLRC1
|
[NCBI]
|
1.91664e-05
|
|
|
POAG
|
[NCBI]
|
1.85877e-05
|
|
|
MAF
|
[NCBI]
|
1.84326e-05
|
|
|
BCL10
|
[NCBI]
|
1.84326e-05
|
|
|
IGER
|
[NCBI]
|
1.81743e-05
|
|
|
EDAR
|
[NCBI]
|
1.7782e-05
|
|
|
ICSBP1
|
[NCBI]
|
1.7782e-05
|
|
|
NFAT5
|
[NCBI]
|
1.7782e-05
|
|
|
HLA-A
|
[NCBI]
|
1.7781e-05
|
|
|
BDNF
|
[NCBI]
|
1.75642e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
1.71978e-05
|
|
|
CXCR3
|
[NCBI]
|
1.71978e-05
|
|
|
DEFB4
|
[NCBI]
|
1.71978e-05
|
|
|
CCR3
|
[NCBI]
|
1.66681e-05
|
|
|
ECGF1
|
[NCBI]
|
1.66681e-05
|
|
|
CD1A
|
[NCBI]
|
1.66681e-05
|
|
|
RFX5
|
[NCBI]
|
1.66681e-05
|
|
|
BPI
|
[NCBI]
|
1.66681e-05
|
|
|
SCIDX1
|
[NCBI]
|
1.66377e-05
|
|
|
PRKCZ
|
[NCBI]
|
1.61835e-05
|
|
|
CD209
|
[NCBI]
|
1.61835e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.61835e-05
|
|
|
SRC
|
[NCBI]
|
1.57487e-05
|
|
|
EBI3
|
[NCBI]
|
1.57372e-05
|
|
|
PCNA
|
[NCBI]
|
1.56412e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.53567e-05
|
|
|
CLEC4M
|
[NCBI]
|
1.53237e-05
|
|
|
CD1D
|
[NCBI]
|
1.53237e-05
|
|
|
ATRN
|
[NCBI]
|
1.49386e-05
|
|
|
SEMA4D
|
[NCBI]
|
1.49386e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.46436e-05
|
|
|
VIL2
|
[NCBI]
|
1.45783e-05
|
|
|
CXCL13
|
[NCBI]
|
1.45783e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
1.424e-05
|
|
|
IL7R
|
[NCBI]
|
1.424e-05
|
|
|
IL17A
|
[NCBI]
|
1.424e-05
|
|
|
EGFR
|
[NCBI]
|
1.41626e-05
|
|
|
DGS
|
[NCBI]
|
1.40283e-05
|
|
|
G6PC2
|
[NCBI]
|
1.39211e-05
|
|
|
TLR4
|
[NCBI]
|
1.37695e-05
|
|
|
NME1
|
[NCBI]
|
1.30623e-05
|
|
|
IL12A
|
[NCBI]
|
1.23205e-05
|
|
|
TLR7
|
[NCBI]
|
1.18772e-05
|
|
|
CD44
|
[NCBI]
|
1.16686e-05
|
|
|
GZMA
|
[NCBI]
|
1.16686e-05
|
|
|
CD4
|
[NCBI]
|
1.16686e-05
|
|
|
MYD88
|
[NCBI]
|
1.16686e-05
|
|
|
CD8A
|
[NCBI]
|
1.14679e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
1.14679e-05
|
|
|
PPIB
|
[NCBI]
|
1.14679e-05
|
|
|
SPP1
|
[NCBI]
|
1.14415e-05
|
|
|
MAG
|
[NCBI]
|
1.11578e-05
|
|
|
IL18
|
[NCBI]
|
1.07337e-05
|
|
|
BL
|
[NCBI]
|
1.0693e-05
|
|
|
CYBB
|
[NCBI]
|
1.0402e-05
|
|
|
IKBKG
|
[NCBI]
|
1.02438e-05
|
|
|
SLAMF1
|
[NCBI]
|
1.00904e-05
|
|
|
PSCA
|
[NCBI]
|
9.79659e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
9.5189e-06
|
|
|
TCRG
|
[NCBI]
|
9.12919e-06
|
|
|
CAT
|
[NCBI]
|
8.83161e-06
|
|
|
C4A
|
[NCBI]
|
8.76784e-06
|
|
|
CTSC
|
[NCBI]
|
8.54092e-06
|
|
|
IFNG
|
[NCBI]
|
8.54092e-06
|
|
|
TLR2
|
[NCBI]
|
8.42765e-06
|
|
|
PRF1
|
[NCBI]
|
8.32413e-06
|
|
|
BLM
|
[NCBI]
|
8.24488e-06
|
|
|
SH2D1A
|
[NCBI]
|
8.11668e-06
|
|
|
WRN
|
[NCBI]
|
8.07892e-06
|
|
|
KIT
|
[NCBI]
|
7.72708e-06
|
|
|
CHAT
|
[NCBI]
|
7.26714e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
7.0018e-06
|
|
|
PTH
|
[NCBI]
|
6.88018e-06
|
|
|
JAK3
|
[NCBI]
|
6.8757e-06
|
|
|
CTNNB1
|
[NCBI]
|
6.64862e-06
|
|
|
CCL2
|
[NCBI]
|
6.57544e-06
|
|
|
CCR5
|
[NCBI]
|
6.50346e-06
|
|
|
TLR3
|
[NCBI]
|
6.43265e-06
|
|
|
GFAP
|
[NCBI]
|
6.35295e-06
|
|
|
MPO
|
[NCBI]
|
5.75174e-06
|
|
|
KLK3
|
[NCBI]
|
5.59285e-06
|
|
|
BTK
|
[NCBI]
|
5.27241e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
5.21956e-06
|
|
|
PRL
|
[NCBI]
|
5.10799e-06
|
|
|
TPO
|
[NCBI]
|
4.56975e-06
|
|
|
VDR
|
[NCBI]
|
4.26378e-06
|
|
|
IFNA1
|
[NCBI]
|
4.25051e-06
|
|
|
VIP
|
[NCBI]
|
4.07881e-06
|
|
|
TG
|
[NCBI]
|
4.01475e-06
|
|
|
PPIA
|
[NCBI]
|
3.90288e-06
|
|
|
UCP2
|
[NCBI]
|
3.86633e-06
|
|
|
G6PD
|
[NCBI]
|
3.45815e-06
|
|
|
DDC
|
[NCBI]
|
3.36164e-06
|
|
|
KDR
|
[NCBI]
|
3.29998e-06
|
|
|
MAP3K5
|
[NCBI]
|
3.20974e-06
|
|
|
IL6
|
[NCBI]
|
2.76995e-06
|
|
|
HP
|
[NCBI]
|
2.7173e-06
|
|
|
PPARA
|
[NCBI]
|
1.54963e-06
|
|
|
AFP
|
[NCBI]
|
1.37794e-06
|
|
|
SDC2
|
[NCBI]
|
1.20863e-06
|
|
|
BCR
|
[NCBI]
|
1.19637e-06
|
|
|
GTS
|
[NCBI]
|
1.08632e-06
|
|
|
ACPP
|
[NCBI]
|
1.07897e-06
|
|
|
CRH
|
[NCBI]
|
9.91295e-07
|
|
|
CD
|
[NCBI]
|
7.51579e-07
|
|
|
PI
|
[NCBI]
|
7.34663e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
7.28686e-07
|
|
|
TF
|
[NCBI]
|
7.07036e-07
|
|
|
F3
|
[NCBI]
|
6.62504e-07
|
|
|
EPO
|
[NCBI]
|
6.59872e-07
|
|
|
GPI
|
[NCBI]
|
6.07052e-07
|
|
|
PMCH
|
[NCBI]
|
4.09789e-07
|
|
|
POMC
|
[NCBI]
|
3.99848e-07
|
|
|
PTK2
|
[NCBI]
|
2.76224e-07
|
|
|
ADCYAP1
|
[NCBI]
|
2.61593e-07
|
|
|
HGF
|
[NCBI]
|
2.41292e-07
|
|
|
GNRH1
|
[NCBI]
|
1.76826e-07
|
|
|
TFPI
|
[NCBI]
|
9.08341e-08
|
|
|
SOD2
|
[NCBI]
|
6.98475e-08
|
|
|
AHR
|
[NCBI]
|
5.84632e-08
|
|
|
ABCC1
|
[NCBI]
|
4.79762e-08
|
|
|
MB
|
[NCBI]
|
3.58135e-08
|
|
|
ALB
|
[NCBI]
|
1.96359e-08
|
|
|
ACE
|
[NCBI]
|
9.67932e-09
|
|
|
CTGF
|
[NCBI]
|
5.56811e-10
|
|